Warten auf den Duke Report

www.cnbc.com/id/35096128/site/14081545

17.02.10, Start des 90 tägigen Beta-Tests

The goal is to expand up to 3 additional facilities as the Beta Test progresses.

Once the Beta Test is complete, Wellstar will move into a Gamma Test. During the Gamma Test, Wellstar will begin charging for the systems and be revenue producing.

www.cnbc.com/id/35436573/site/14081545

finance.yahoo.com/q/is?s=wlsi.ob

Management's Discussion and Analysis of Financial Condition and Results of Operations

biz.yahoo.com/e/100318/wlsi.ob10-q.html

Unregistered Sale of Equity Securities, Financial Statements and Exh

biz.yahoo.com/e/100318/wlsi.ob8-k.html

bei strategischen Visionen, betriebliche und finanzielle Leistungen

www.ad-hoc-news.de/...rm--/de/Unternehmensnachrichten/21204377

in the Long Term Care Facility

The original goal was to expand up to 3 additional facilities as the Beta Test progresses. Wellstar is now looking to expand the testing in up to 10 different facilities. Wellstar expects to be in an additional facility within the next 15 days.

www.marketwatch.com/story/...t-2010-04-15?reflink=MW_news_stmp

Wellstar International Inc (OTCBB: WLSI) has announced they will be installing a system in Torrance, California.Wellstar will be installing a TMI Imaging system in a Doctor's office in Torrance, California.

The system will be shipped by the end of April and installed and operational on or before May 10, 2010.


www.ad-hoc-news.de/...on--/de/Unternehmensnachrichten/21226190

kann ich die in new york nicht kaufen?????

Kann mir irgendjemand hier kurz erklären was dieses Unternehmen macht ?
Danke und Gruß :-)

Haben den Trillenium Medical Imaging (TMI) mit Software entwickelt. Zur Früherkennung verschiedene Krebsarten durch Änderung der Körpertemperatur mit Hilfe von Infrarotthermalbildaufbereitung

TMI stellt funktionelle Bildaufbereitungssysteme durch den Gebrauch der Infrarotentdeckung zur Verfügung.
Die Technologie ist erfolgreich geprüft worden und ist zurzeit im Gebrauch, um bei der Diagnose der Behandlungsüberwachung und dem Fall-Management von vielen Gesundheitsproblemen zu helfen. Diese schließen ein, ist aber nicht beschränkt auf: Neurologische Gefäß- und Muskulös-Skelettunordnungen wie Brustkrebs, Zuckerkrankheit, und ungelöste Schmerzprobleme, die mit myofascial Beschwerden, Muskelverletzung oder neurologischer Funktionsstörung verbunden sind.


Gerät mit Software wurde bereits von der FDA zugelassen.
Die Duke University Study verlief ebenfalls positiv.

Erste Auslieferung ende April an einen Arzt in Kalifornien

www.wellstar.us

liegt vllt an deinem Broker.
Ich kann OTC kaufen.

soweit kann ich auch andere otc werte kaufen nur diesen nicht.und berlin bremen ist sch.....

in deutschland würde ich auch nicht kaufen, volumen zu gering - wenn überhaupt eins vorhanden ist.

das problem habe ich mit meinem anbieter bei vorzügen von wamu. werden nicht alle otc bb werte angeboten

also bei mir läuft das so, vor graumer zeit konnte ich eine Aktie beim Sbroker nicht über Tradegate handeln - Email geschrieben, 1 Tag später gings auch über Tradegate.

Gleiches Problem wie Du hatte ich gestern mit einer anderen Aktie beim Sbroker - Email geschrieben - heute kann ich die Aktie über OTC kaufen. 

Vielleicht mal auf diesem Wege probieren, bei mir handelt es sich so man mir sagte um Aktien die bisher nicht bei Ihnen gehandelt wurden bzw. Handelsplätze die noch nicht angefragt wurden.

 

The system will be shipped by the end of May and installed and operational before the middle of June 2010.

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operation results.

www.ad-hoc-news.de/...w-installation--/de/Nachrichten/21251768

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operation results.

www.finanzen.net/nachricht/...plementation-of-Beta-Test-786672

months of initial roll-out,through 2010. That number will increase
to
400 per month by2011. There are nearly 16,000 LTCfacilities in the
United States, anda pending need for more with an aging population
that isincreasing in numbers year after year.
Fairhills Capital is aprivate equity firm that invests capital into
companies in theemerging markets. The firm pursues investment
opportunities insmall-cap companies that have a strong management
team and theability to implement their business plan.Fairhills
Capital has invested in over 50 public and privatecompanies in
various sectors including oil and gas, communication,arts and
entertainment, services and healthcare / medical products.
Wellstar's CEO, John Antonio, stated: "We are pleased thatFairhills
Capital shares our excitement and eagerness to beginrolling out our
thermal imaging systems. The epidemic of bed sorescontinues to rise
and we anticipate the demand for these systemsamong just the long-
term care facilities to be tremendous. We havean enormous and
largely
untouched market to go after with ourrevolutionary system. With
early
detection of this veryserious epidemic, we have the ability to help
save and extend manylives."
ABOUT WELLSTAR INTERNATIONAL, INC.
WellstarInternational, Inc., through its wholly owned operating
subsidiaryTrillenium Medical Imaging, Inc. (TMI), is poised to
become
aleading diagnostic company in the health care industry. TMI has
developed and is marketing fully calibrated and functional, thermal
imaging systems that utilize state-of-the-art infrared technologies
and proprietary software to accurately and cost-effectively measure
physiological changes in the human body. More information on the
Company and its unique diagnostic software and product line is
available on Wellstar's corporate Website by visiting: www.wellstar.us
FORWARD-LOOKING STATEMENTS

Wellstar International, Inc. seeks to be the first-to-market in deep tissue injury and pressure ulcer detection using its proprietary infrared imaging system. Thermal Imaging is a low cost, noncontact, non-radioactive diagnostic screening procedure designed for clinical evaluation. In addition, thermal imaging provides an ability to track the progress of therapies being utilized in a low cost, non-invasive manner. Thermal Imaging can detect signs of pressure ulcers before they are visible with the naked eye through detection of temperature changes at the site which allows for treatment of the pressure ulcer before it erupts. The TMI system can be used to scan all new patients into hospitals and long-term care facilities prior admittance and begin treating existing wounds before they are visible.
Wellstar’s believes that the first emphasis on marketing their systems will be to the LTAC Industry. There are over 700 of these facilities in the US and their uses will correlate with the facilities that are involved or will be involved with the Beta Test. This should lead to over 1 million dollars per month in revenue for Wellstar.
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operation results.

www.finanzen.net/nachricht/...nces-Success-in-Beta-Test-792200

ja so als gibt es hier wenig anhänger von dieser aktie, ist wohl doch nur mist?!

ja hier auch nichts zu diskutieren.

Die werden ihren weg machen und in 6 - 7 Monaten (bei einer eventl. Vermarktung) sind wir schlauer.

nicht trotzdem schon eher ein paar nicht ganz unwichtige neuigkeiten rauskommen, der artikel klang ja für mich nicht schlecht, wie siehst du das.

bis zum ziel.
sie bringen in etappen immer positive news. alles setzt sich in kleinen schrittenm zusammen und dann (hoffentlich) die große neuigkeit: die vermarktung.

der beta test ist bis jetzt positiver ausgefallen als von ihnen erwartet,... erste auslieferungen bei ärzten.

das puzzle setzt sich zusammen und augenscheinlich nimmt es keiner wahr.

ih.advfn.com/...mona&article=42812826&symbol=NB%5EWLSI

Date : 05/13/2010 @ 4:32PM
Source : Edgar (US Regulatory)
Stock : (WLSI)
Quote :  0.0007  -0.0002 (-22.22%) @ 9:19AM


- Current report filing (8-K)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934


Date of Report (Date of earliest reported): May 5, 2010


WELLSTAR INTERNATIONAL, INC.
(Exact name of registrant as specified in charter)


Nevada  333-130295  20-1834908  
(State  or  Other  Jurisdiction of Incorporation or Organization)  (Commission File Number)  (IRS Employer Identification No.)  

 
 
6911 Pilliod Road
Holland, Ohio 43528
(Address of principal executive offices) (Zip Code)


Registrant's telephone number, including area code: (419) 865-0069




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 
--------------------------------------------------

 
                                     
Item 1.01       Entry Into A Material Definitive Agreement  
Item 2.03     Creation of a Direct Financial Obligation.  
Item 3.02       Unregistered Sales of Equity Securities.  



On May 5, 2010,Wellstar International, Inc. ("Wellstar" or the "Company") entered into  a  Securities   Purchase   Agreement   with  Asher Enterprises, Inc. ("Asher"), for the sale of an 8% convertible note in the principal amount of $50,000 (the "Note").  The financing closed on May 5, 2010.


The Note bears interest at the rate of 8% per annum.  All interest and principal must be repaid on February 5, 2011.  The Note is convertible into common stock, at Asher’s option, at a 40% discount to the average of the three lowest trading prices of the common stock during the 10 trading day period prior to conversion.  The Note contains a prepayment option whereby the Company may make a payment to Asher equal to 150% of all amounts owed under the Note.  The Company is required to provide Asher with 30 days notice of such prepayment.


Asher has agreed to restrict its ability to convert the Note and receive shares of common stock such that the number of shares of common stock held by them in the aggregate and their affiliates after such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of common stock.


The  Company  claims an  exemption  from the  registration  requirements  of the Securities  Act of 1933,  as amended  (the "Act") for the private  placement  of these  securities  pursuant  to  Section  4(2) of the Act  and/or  Regulation  D promulgated  there under since,  among other  things,  the  transaction  did not involve a public  offering,  Asher is an accredited  investor.  Asher had access to information about the Company  and their  investment,  Asher  took the  securities  for investment and not resale, and the Company took appropriate measures to restrict the transfer of the securities.


Item 9.01 Financial Statements and Exhibits


(c) Exhibits.


                       
Exhibit
Number      
  Description  
4.1  Securities  Purchase  Agreement, dated  May 5, 2010, by and among the Company and the Asher Enterprises, Inc.  
     
4.2  Convertible Promissory Note  





SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  WELLSTAR INTERNATIONAL, INC.    
           
Date: May 12, 2010  By:  /s/ John Antonio    
     Name: John Antonio      
     Title: CEO

frage ich mich ja schon, wenn diese firma solch gute aussichten hat, weshalb steht sie dann dort wo sie jetzt steht.